Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Application for Modification of the 2022 European Leukemianet Genetic Risk Stratification in Pediatric Acute Myeloid Leukemia

Blood (2024) 144 (Supplement 1): 4313.

https://doi.org/10.1182/blood-2024-201637

Published: 2024

Journal Articles

CRISPR/dCas9 (D10A) -Mediated Hb CS Gene Editing and Identification of Genetically Modified Fibroblasts

Lian Yu, Wei Hao Wu, WANG Shunqing, Ken H. Young, Funeng Jiang, PhD

Blood (2019) 134 (Supplement_1): 5754.

https://doi.org/10.1182/blood-2019-129931

Published: 2019

Journal Articles

Low-Dose Interleukin-2 Restores Human Regulatory T Cell Function, in Vitro , As a Potential in the Handle of Graft Versus Host Disease (GvHD)

Tzeon-Jye Chiou, MD, Hsiu-Hsia Lin, PhD, Wei-Hao Wu, BS, Jhih-Yun Jian, MS, Sin-Tak Chu, PhD, Woan-Fang Tzeng, PhD

Blood (2017) 130 (Supplement 1): 5450.

https://doi.org/10.1182/blood.V130.Suppl_1.5450.5450

Published: 2017

Journal Articles

Expansion and Reactivation of Human Naïve T-Cells Transition into CD4+CD25+FoxP3+CD127-Regulatory T Cells, In Vitro , for the Potential Use of Graft-Versus-Host Disease Prevention

Tzeon-Jye Chiou, MD, Tien-Hua Chu, PhD, Wei-Hao Wu, MS, Sin-Tak Chu, PhD, Woan-Fang Tzeng, PhD

Blood (2016) 128 (22): 5729.

https://doi.org/10.1182/blood.V128.22.5729.5729

Published: 2016

Journal Articles

In Vivo Phycocyanin Treatment of S180 Bearing-Mice: Increase in Immunic Function and Inhibition of Tumor Growth.

Ling Pan, Wei Hao, Xuejun Zhang, Zhiyun Niu, Fuxu Wang, Zuoren Dong

Blood (2006) 108 (11): 5191.

https://doi.org/10.1182/blood.V108.11.5191.5191

Published: 2006

NARROW

Clinical Application for Modification of the 2022 European Leukemianet Genetic Risk Stratification in Pediatric Acute Myeloid Leukemia

CRISPR/dCas9 (D10A) -Mediated Hb CS Gene Editing and Identification of Genetically Modified Fibroblasts

Low-Dose Interleukin-2 Restores Human Regulatory T Cell Function, in Vitro , As a Potential in the Handle of Graft Versus Host Disease (GvHD)

Expansion and Reactivation of Human Naïve T-Cells Transition into CD4+CD25+FoxP3+CD127-Regulatory T Cells, In Vitro , for the Potential Use of Graft-Versus-Host Disease Prevention

In Vivo Phycocyanin Treatment of S180 Bearing-Mice: Increase in Immunic Function and Inhibition of Tumor Growth.

Email alerts

ASH Publications

American Society of Hematology

Clinical Application for Modification of the 2022 European Leukemianet Genetic Risk Stratification in Pediatric Acute Myeloid Leukemia

CRISPR/dCas9 (D10A) -Mediated Hb CS Gene Editing and Identification of Genetically Modified Fibroblasts

Low-Dose Interleukin-2 Restores Human Regulatory T Cell Function, in Vitro , As a Potential in the Handle of Graft Versus Host Disease (GvHD)

Expansion and Reactivation of Human Naïve T-Cells Transition into CD4+CD25+FoxP3+CD127-Regulatory T Cells, In Vitro , for the Potential Use of Graft-Versus-Host Disease Prevention

In Vivo Phycocyanin Treatment of S180 Bearing-Mice: Increase in Immunic Function and Inhibition of Tumor Growth.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only